Innovative solutions to the greatest challenges in pharmaceutical development

9th – 11th March 2020 | Berlin

Key themes for the 11th Global Drug Delivery & Formulation Summit include:

  • New modalities research opportunities and challenges
  • Personalised therapies, mRNA, Cell and gene therapies
  • Analytical techniques for biotherapeutics
  • 3D printing, flexible manufacturing techniques, continuous manufacturing
  • Multivariate analysis techniques, production process optimisation, digitalisation of
  • pharmaceutical development
  • mAb and bispecific formulation development
  • Oral delivery of biologics and other routes
  • Device development, microneedles, connected devices
  • Integrating human factors into device development, behavioural design

Download 2020 Brochure

2020 Speakers

Anand Subramony

AstraZeneca

Vice President, External Innovation & Novel Technologies

Conference Chairperson

Patrick Garidel

Boehringer Ingelheim

Associate Director Protein Science

Room 2 Chairperson

Matthias Erber

Bayer

Laboratory head in Formulation Development Parenterals

Room 3 Chairperson

Bastiaan DeLeeuw

Cambridge Design Partnership

Head of Business Development – Drug Delivery

Room 4 Chairperson (Day 1)

Matthew Clemente

Novo Nordisk

Vice President, Device Development

Room 4 Chairperson (Day 3)

Amrit Paudel

Graz University of Technology, Research Center Pharmaceutical Engineering (RCPE)

Assistant Professor & Principal Scientist

Andreas Abend

MSD

Director Analytical Sciences

Dr. Andreas Sauer

SE Tylose GmbH & Co. KG

Technical Sales Director

Dr. Andreas Seidl

LEUKOCARE AG

Chief Operating Officer

Andrew Lewis

Quotient Sciences

Vice President, Pharmaceutical Sciences

Anna Luczak

Bristol-Myers Squibb

Senior Scientist

Anne Moore

University College Cork

Professor

Arwyn T. Jones

Cardiff University

Professor of Membrane Traffic and Drug Delivery, and Director of Reseach Cardiff school of Pharmacy and Pharmaceutical sciences

Benoit Koumurian

Sanofi

Drug Product Process Engineer

Bertil Abrahamsson

AstraZeneca

Senior Principal Scientist

Birger Brodin

University of Copenhagen

Professor

Charles Evans

MedPharm

VP of Pharmaceutical Development

Dr. Christian Lotz

Pfanstiehl

General Manager, EMEA

Clare Beddoes

Cambridge Design Partnership

Senior medical innovation and research consultant

Claus-Michael Lehr

Helmholtz Institute for Pharmaceutical Research Saarland

Head of the Department Drug Delivery

Dr. Clemens Günther

Bayer

Director Nonclinical Safety CC

Daniel Bonner

PureTech Health

Vice President

David Lyon

Lonza

Senior Fellow, Research

Dennis Douroumis

University of Greenwich

Professor in Pharmaceutical Technology and Process Engineering, Director of Centre for Innovation in Process Engineering and Research (CIPER)

Dr Vivek Trivedi

University of Kent

Lecturer, Formulation Science Department of Pharmaceutical, Chemical and Environmental Sciences

Dr. Marco Emgenbroich

LTS Lohmann

Corporate Vice President Head of Pharmaceutical Development I R&D

Dr. Michael Black

BENEO-Palatinit GmbH

Head of Sales Pharma

Dr. Sharareh Salar-Behzadi

Research Center Pharmaceutical Engineering (RCPE)

Principal Scientist

University of Graz, Department for Pharmaceutical Technology and Biopharmacy

Tony Listro

Foster Delivery Science

Vice President, Technology

Ferdinand Brandl

BASF SE, Nutrition and Health, Development Pharma Solutions

Head of Laboratory

Gregoire Schwach

Roche

E2E Home Leader Ocular and Drug Delivery

Heinrich Haas

BioNTEch RNA Pharmaceuticals

Vice President RNA Formulation & Drug Delivery

James Humphrey

Croda

Applications Specialist

Jan Nordmann

Roche

Product Care Leader, Device and Packaging Development Europe

Jatin Patel

Constellation Pharmaceuticals

Executive Director-CMC

Jean-René Authelin

Sanofi

Global Head of Pharmaceutical Engineering

Joao Miguel Freire

Janssen

Scientist Formulation Science & Technology (FST)

Joel Gresham

Crux Product Design Ltd.

Simulation Expert & Life Sciences Lead

John C. Shelley

Schrödinger

Schrödinger Fellow

Jonas Fransson

Swedish Orphan Biovitrum AB

Director of Drug Product Development

Kristin Lehmkemper

AbbVie

Senior Scientist

Luigi Boltri

Adare Pharmaceuticals

Director, Technology Development

Dr. Magdalena Obarzanek-Fojt

Novartis

Drug Product Leader within Cell and Gene Technical Development

Mara van Haandel

DFE pharma

Innovation Manager

Marie Leman

Sanofi

R&D project manager / Microfluidics and Biotechnologies

Mike Tate

Boehringer Ingelheim

Human Factors Manager

Mike Tobyn

Bristol-Myers Squibb

Research Fellow

Agathe Buffard

Novartis

Human Factors – Device Manager I

Nima Aghajari

Sanofi

Senior Simulation Engineer

Omar Naneh

Novartis

Senior scientist BPD DPD Operational Sciences

Paolo Avalle

MSD

Associate Principal Scientist

Professor Ijeoma Uchegbu

UCL School of Pharmacy

Chair in Pharmaceutical Nanoscience

Professor Khuloud Al-Jamal

King’s College London

Chair of Drug Delivery & Nanomedicine

Rachel Hu

Cristal Therapeutics

Senior Formulation Scientist

Rene Holm

Janssen

Head and Scientific Director, Liquids & Parenterals

Rene van Nostrum

Utrecht University

Associate professor

Richard Green

Pfizer

Senior Director, Pharmaceutical Sciences

Rob Steendam

InnoCore Pharmaceuticals

Chief Technology Officer

Ronny Reinberg

Intec Pharma

Vice President Technology Affairs

Russ Hornung

W.L. Gore & Associates

Business Development- Drug Delivery and Packaging

Rémy Kohler

Roche

Human Factors Engineer, Device and Packaging Development

Sachin Dubey

Ichnos Sciences

Deputy Director - Process Sciences I

Satya Kishore Ravuri

Roche

Senior Group Leader, Early-Stage Pharmaceutical and Processing Development

Serge Mathonet

Sanofi

Global Regulatory Affairs Biologics Center CMC Interface

Shalini Andersson

AstraZeneca

Chief Scientist New Therapeutic Modalities

Shiqi Hong

Roquette

Senior biopharma scientist

Aleksandra Dabkowska

AstraZeneca

Associate Principal Scientist

Sudhakar Garad

Novartis Institutes for BioMedical Research

Global Head of Chemical and Pharmaceutical Profiling

Sven Stegemann

Graz University of Technology

Professor for Patient Centric Drug Development and Manufacturing

Thomas Schmidt

Novartis

Principal Scientist

Thomas Kipping

Merck

Head of Drug Carriers

Torsten Kneuss

Bayer

QA Manager Combination Products

Twinkle Christian

Amgen

Process Development Scientist, Drug Product Technologies department

Werner Hoheisel

Invite

Group Lead Formulation Technologies

Ildiko Terebesi

Bayer

Head of Drug Delivery Innovation

Alan S Harris

Ferring

Senior VP GLOBAL R&D LCM

Louise Place

Cambridge Design Partnership

Head Of Regulatory Affairs

Richard Featherstone

Emergo by UL

Research Director, Human Factors Research and Design

Dr. Christoph Brandenbusch

TU Dortmund

Group Leader

Guillaume Brouet

Aptar Pharma

Vice-President - Analytical, Regulatory and Scientific Affairs

David Ward

Intertek

Formulation and Manufacturing Lead

John Majewski

Gilead Sciences

Device Development Engineer

Bernhard Muellinger

Vectura

Vice President - Inhalation Technology

Muhammad Akhtar

The Islamia University of Bahawalpur

Associate Professor at Faculty of Pharmacy and Alternative Medicine

Christian Jones

Nanoform

Chief Commercial Officer

Steven Ross

University of Greenwich

Research Associate in pharmaceutical processes Pharmaceutical

Andreas Bernkop-Schnürch

University of Innsbruck

Research Group Drug Delivery and Powder Technology

Josef Hartl

Boehringer Ingelheim

Scientist

Davide Mercadante

Biogen

Senior Device Quality Engineer, Device Development Quality

Mark A. Hassett

Credence MedSystems

Vice President of Business Development

×

Latest News

Partner profile: Crux Product Design

With the experience of delivering product innovations in the medical, consumer and performance goods sectors, we have the expertise to adapt and apply our methods to each client’s specific project needs.

Updates from Sensile Medical

Our partner Sensile Medical have an update on two of its major projects: The recent market launch of their first micropump, an infusion pump for Parkinson's disease patients; and their latest project with SQ Innovation for a 3mL furosemide patch pump. they have sent us 3 documents to present to our followers and audience

Upperton is Launching an Enabling Technology Screening Protocol

The new enabling technology screening platform, integrates the company’s existing formulation capabilities with a biopharmaceutical assessment and streamlines the early development processes by clearly identifying the most appropriate formulation strategy for clinical success.